Log in

NYSE:SYK - Stryker Stock Price, Forecast & News

$203.99
+0.78 (+0.38 %)
(As of 12/8/2019 04:00 PM ET)
Today's Range
$203.61
Now: $203.99
$205.19
50-Day Range
$198.66
MA: $206.99
$220.63
52-Week Range
$144.75
Now: $203.99
$223.45
Volume1.44 million shs
Average Volume1.17 million shs
Market Capitalization$76.31 billion
P/E Ratio27.91
Dividend Yield1.02%
Beta0.75
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP86366710
Phone269-389-2600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.60 billion
Cash Flow$9.40 per share
Book Value$31.35 per share

Profitability

Net Income$3.55 billion

Miscellaneous

Employees36,000
Market Cap$76.31 billion
Next Earnings Date2/4/2020 (Estimated)
OptionableOptionable

Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.


Stryker (NYSE:SYK) Frequently Asked Questions

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker announced a quarterly dividend on Thursday, December 5th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.575 per share on Friday, January 31st. This represents a $2.30 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date is Monday, December 30th. This is an increase from Stryker's previous quarterly dividend of $0.52. View Stryker's Dividend History.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) announced its quarterly earnings results on Tuesday, October, 29th. The medical technology company reported $1.91 EPS for the quarter, topping the Zacks' consensus estimate of $1.90 by $0.01. The medical technology company had revenue of $3.59 billion for the quarter, compared to the consensus estimate of $3.58 billion. Stryker had a return on equity of 25.33% and a net margin of 23.55%. The company's quarterly revenue was up 10.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.69 earnings per share. View Stryker's Earnings History.

When is Stryker's next earnings date?

Stryker is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Stryker.

What guidance has Stryker issued on next quarter's earnings?

Stryker updated its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided earnings per share (EPS) guidance of $2.43 to $2.48 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.45.

What price target have analysts set for SYK?

20 analysts have issued 12-month target prices for Stryker's stock. Their forecasts range from $156.75 to $245.00. On average, they anticipate Stryker's share price to reach $218.36 in the next twelve months. This suggests a possible upside of 7.0% from the stock's current price. View Analyst Price Targets for Stryker.

What is the consensus analysts' recommendation for Stryker?

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 4 hold ratings and 16 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Stryker.

Has Stryker been receiving favorable news coverage?

News headlines about SYK stock have trended very negative on Sunday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Stryker earned a coverage optimism score of -3.0 on InfoTrie's scale. They also gave news coverage about the medical technology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Stryker.

Are investors shorting Stryker?

Stryker saw a decline in short interest in the month of October. As of October 15th, there was short interest totalling 3,670,000 shares, a decline of 23.2% from the September 15th total of 4,780,000 shares. Based on an average daily volume of 1,020,000 shares, the short-interest ratio is presently 3.6 days. Currently, 1.1% of the shares of the stock are short sold. View Stryker's Current Options Chain.

Who are some of Stryker's key competitors?

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Visa (V), Abbott Laboratories (ABT), Walt Disney (DIS), Home Depot (HD), AbbVie (ABBV), Medtronic (MDT), Bank of America (BAC), CVS Health (CVS) and Cisco Systems (CSCO).

Who are Stryker's key executives?

Stryker's management team includes the folowing people:
  • Mr. Kevin A. Lobo, Chairman & CEO (Age 54)
  • Mr. Timothy J. Scannell, Pres & COO (Age 54)
  • Mr. Glenn S. Boehnlein, VP & CFO (Age 57)
  • Mr. Michael D. Hutchinson, VP & Chief Legal Officer (Age 48)
  • Mr. Lonny J. Carpenter, Group Pres & Adviser to the CEO (Age 57)

Who are Stryker's major shareholders?

Stryker's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (3.60%), Massachusetts Financial Services Co. MA (1.47%), California Public Employees Retirement System (0.36%), Sumitomo Mitsui Trust Holdings Inc. (0.35%), Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.34%) and Parametric Portfolio Associates LLC (0.27%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, David Floyd, Glenn S Boehnlein, Graham A Mclean, Howard E Cox Jr, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell, William E Berry Jr and Yin C Becker. View Institutional Ownership Trends for Stryker.

Which major investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Keybank National Association OH, Alberta Investment Management Corp, Pictet Asset Management Ltd., Connors Investor Services Inc., Mackay Shields LLC, Man Group plc and Ferguson Wellman Capital Management Inc.. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Srikant M Datar, Timothy J Scannell and Yin C Becker. View Insider Buying and Selling for Stryker.

Which major investors are buying Stryker stock?

SYK stock was purchased by a variety of institutional investors in the last quarter, including State Street Corp, State of New Jersey Common Pension Fund D, First Trust Advisors LP, California Public Employees Retirement System, Columbus Circle Investors, Commerzbank Aktiengesellschaft FI, Stonehage Fleming Financial Services Holdings Ltd and State of Michigan Retirement System. View Insider Buying and Selling for Stryker.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $203.99.

How big of a company is Stryker?

Stryker has a market capitalization of $76.31 billion and generates $13.60 billion in revenue each year. The medical technology company earns $3.55 billion in net income (profit) each year or $7.31 on an earnings per share basis. Stryker employs 36,000 workers across the globe.View Additional Information About Stryker.

What is Stryker's official website?

The official website for Stryker is http://www.strykercorp.com/.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]


MarketBeat Community Rating for Stryker (NYSE SYK)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  735 (Vote Outperform)
Underperform Votes:  714 (Vote Underperform)
Total Votes:  1,449
MarketBeat's community ratings are surveys of what our community members think about Stryker and other stocks. Vote "Outperform" if you believe SYK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SYK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel